News Results
There are 795,787 News Results
Nov 30, 2017
DUBLIN, December 1, 2017 /PRNewswire/ -- The "Electric Vehicles 2018-2038: Forecasts, Analysis and Opportunities" report has been added to
Nov 30, 2017
PLANO, Texas, Dec. 1, 2017 /PRNewswire/ -- Toyota Motor North America (TMNA) Inc., today reported November 2017 sales of 191,617 units. With the same number of selling days in November...
Dec 3, 2017
LAVAL, Quebec, Dec. 4, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant") and Valeant Pharmaceuticals International ("VPI," and together with Valeant, the "Offerors"), a wholly-owned subsidiary...
Dec 6, 2017
SILVER SPRING, Md., Dec. 7, 2017 /PRNewswire-USNewswire/ -- Today we're announcing three new, significant policy documents to advance the FDA's approach to the development and proper oversight of innovative digital...
Dec 6, 2017
SILVER SPRING, Md., Dec. 7, 2017 /PRNewswire-USNewswire/ -- Today we're announcing three new, significant policy documents to advance the FDA's approach to the development and proper oversight of innovative digital...
Dec 7, 2017
WOODCLIFF LAKE, N.J., Dec. 8, 2017 /PRNewswire/ -- Eisai Inc. today announced updated results of ENHANCE 1, a Phase 1b/2 trial investigating eribulin mesylate (marketed as HALAVEN(®), "eribulin"), in combination...
Dec 11, 2017
UPPSALA, Sweden, Dec. 12, 2017 /PRNewswire/ -- Orexo AB today announces specific information about the improved market access position for Zubsolv (buprenorphine and naloxone) sublingual tablet (CIII) in the US...
Dec 20, 2017
NEW YORK, Dec. 21, 2017 /PRNewswire/ -- At a seasonally adjusted annual rate of $650.5 billion, new construction starts in November dropped 12% from October, according to Dodge Data &...
Dec 27, 2017
MCLEAN, Va., Dec. 28, 2017 /PRNewswire/ -- The U.S. military saw a number of newsworthy events during the past year, from the swearing in of a new president and commander-in-chief...
Jan 2, 2018
EAST HANOVER, N.J., Jan. 3, 2018 /PRNewswire/ -- Novartis today announced Kisqali(® )(ribociclib) received US Food and Drug Administration (FDA) Breakthrough Therapy designation for initial endocrine-based treatment of pre- or...
